IL17A and neoplasm: Conversely, in glioblastoma and certain lung cancers, γδ T cells have been shown to skew toward an IL-17-producing phenotype, which may promote tumor progression by enhancing angiogenesis and recruiting myeloid-derived suppressor cells (162, 163).